z-logo
open-access-imgOpen Access
Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
Author(s) -
Nicosia Dario,
Federico Antonino,
Vigna Ivan,
Iozzo Pasquale,
Misseri Giovanni,
Cortegiani Andrea
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2061
Subject(s) - medicine , bolus (digestion) , anesthesia , intravenous bolus , recombinant factor viia , percutaneous , surgery , recombinant dna , factor viia , coagulation , biochemistry , chemistry , tissue factor , gene
Key Clinical Message In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15‐20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here